is a cardiac glycoside used in heart failure
to increase cardiac contractility and decrease heart rate. It directly inhibits the sodium/potassium ATPase pump, causing indirect inhibition of the sodium/calcium exchanger pump and leading to increased intracellular levels of calcium. This increases contractility. It also directly stimulates the vagus nerve to decrease heart rate. Side effects are mostly cholinergic, and include blurry vision with yellow haloes around objects, arrhythmias (most common cardiac side effect), and AV block
in a patient on digoxin indicates a poor prognosis. Hypokalemia
predisposes to digoxin toxicity, as do renal failure
and certain drugs like amiodarone
, and quinidine
. Treatment of overdose is by slowly normalising potassium levels, cardiac pacing, magnesium infusion, and anti-digoxin Fab fragments.